Low-dose aspirin recall due to improper storage temperature conditions
Cardinal Healthcare is recalling low-dose aspirin tablets nationwide due to a CGMP deviation involving improper storage temperatures. Products may have been exposed to conditions outside the manufacturer's labeled storage requirements, potentially affecting product stability.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 3/5 (High).
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall for a CGMP deviation involving exposure to improper storage temperatures. No illnesses, injuries, or hospitalizations are reported in the source. The hazard is theoretical—improper storage could affect drug stability and efficacy—but without documented adverse health effects, it meets the criteria for High severity.
Plain-English summary
Cardinal Healthcare is recalling Low Dose Aspirin 81 mg tablets (batch P126201) nationwide due to a Good Manufacturing Practice (CGMP) deviation. The products were exposed to temperatures outside of the labeled storage conditions, which could affect product stability and efficacy.
The affected product is a 120 tablet bottle of enteric-coated aspirin distributed by Rugby Laboratories. The batch number P126201 with NDC 0536-1234-41 has been identified as part of this recall. The recall is nationwide.
Consumers who have purchased this product should consult with a pharmacist or healthcare provider about the affected batch. Check your medication bottle for batch number P126201 and the recalled NDC number. Ask your pharmacist about proper disposal methods.
The recalled product
- Product
- ASPIRIN (ASPIRIN)
- Brand
- ASPIRIN
- Manufacturer
- CARDINAL HEALTHCARE
- Category
- Drug — OTC Medication
- Affected units
- 2
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Batch P126201
UPCs (1)
- 0305361234416
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 42 recalled by CARDINAL HEALTHCARE under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 42 products in this recall →Related recalls
Same brand · ASPIRIN
- ModerateAspirin 81 mg chewable tablets recalled due to packaging defect
FDA (Drugs) · 2024-11-27
Same manufacturer · CARDINAL HEALTHCARE
See all →- HighAlbuterol Sulfate Inhaler Recalled Due to Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- ModerateMeloxicam 15 mg tablets recalled for exposure to improper storage temperatures
FDA (Drugs) · 2024-01-03
- HighPredniSONE Tablets Recalled for Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- HighBumetanide Tablets Recalled for Exposure to Improper Storage Temperatures
FDA (Drugs) · 2024-01-03
- HighLithium Carbonate Extended-Release Tablets Recalled for Temperature Excursion
FDA (Drugs) · 2024-01-03
Same hazard · temperature deviation
See all →- ModerateCitalopram Tablets Recalled for Temperature Storage Deviation
FDA (Drugs) · 2024-01-03
- HighDonepezil Hydrochloride Tablets Recalled Due to Storage Temperature Deviations
FDA (Drugs) · 2024-01-03
- ModerateLeader Nasal Decongestant PE recalled due to improper storage conditions
FDA (Drugs) · 2024-01-03
- ModerateAmoxicillin oral suspension recalled for temperature storage deviation
FDA (Drugs) · 2024-01-03
- HighAdvil Ibuprofen 200mg tablets recalled due to improper storage conditions
FDA (Drugs) · 2023-05-10
Similar recalls
- ModerateCardinal Health Recalls Amoxicillin Tablets Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateAspirin Products Recalled Due to Improper Storage Conditions at Family Dollar
FDA (Drugs) · 2022-08-31
- ModerateCardinal Health Recalls Haloperidol Tablets Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls Niacin Tablets Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls Leucovorin Tablets Due to Temperature Excursions
FDA (Drugs) · 2021-06-02
- ModerateCardinal Health Recalls Enalapril Maleate Tablets Due to Storage Temperature Excursions
FDA (Drugs) · 2021-06-02